Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence SZ Alshawwa, AA Kassem, RM Farid, SK Mostafa, GS Labib Pharmaceutics 14 (4), 883, 2022 | 113 | 2022 |
Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy AO Elzoghby, SK Mostafa, MW Helmy, MA ElDemellawy, SA Sheweita Pharmaceutical research 34, 1956-1969, 2017 | 70 | 2017 |
Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy AO Elzoghby, SK Mostafa, MW Helmy, MA ElDemellawy, SA Sheweita International journal of pharmaceutics 529 (1-2), 178-192, 2017 | 51 | 2017 |
Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and … MH Ibrahim, MF Harras, SK Mostafa, SM Mohyeldin, N Altwaijry, R Sabour Bioorganic Chemistry 129, 106122, 2022 | 9 | 2022 |
Preclinical studies on melanogenesis proteins using a resveratrol-nanoformula as a skin whitener SA Sheweita, YM El-Masry, TI Zaghloul, SK Mostafa, NA Elgindy International Journal of Biological Macromolecules 223, 870-881, 2022 | 2 | 2022 |
Therapeutic approaches employed in cardiac surgery to manage postoperative atrial fibrillation. SK Mostafa Delta University Scientific Journal 5 (2), 2022 | | 2022 |